A progressive discovery strategy for anti-Alzheimer's drug identification:In vitro screening with an LPS-induced neuroinflammatory cell model and in vivo validation in 5xFAD mice
Junyi Zhou Hongping Hou Xiaolu Wei Haiyu Zhao Linna Wang Lianmei Wang Pengyue Li Yan Zhang Yuheng Wang Yan Rong Lihua Chen Huijun Wang
中医药科学(英文)2026,Vol.4Issue(3):255-269,15.
中医药科学(英文)2026,Vol.4Issue(3):255-269,15.DOI:10.1097/st9.0000000000000100
A progressive discovery strategy for anti-Alzheimer's drug identification:In vitro screening with an LPS-induced neuroinflammatory cell model and in vivo validation in 5xFAD mice
A progressive discovery strategy for anti-Alzheimer's drug identification:In vitro screening with an LPS-induced neuroinflammatory cell model and in vivo validation in 5xFAD mice
摘要
关键词
5xFAD mice/AD cell line construction/Alzheimer's disease/Benzoylaconitine/Metabolomics/NeuroinflammationKey words
5xFAD mice/AD cell line construction/Alzheimer's disease/Benzoylaconitine/Metabolomics/Neuroinflammation引用本文复制引用
Junyi Zhou,Hongping Hou,Xiaolu Wei,Haiyu Zhao,Linna Wang,Lianmei Wang,Pengyue Li,Yan Zhang,Yuheng Wang,Yan Rong,Lihua Chen,Huijun Wang..A progressive discovery strategy for anti-Alzheimer's drug identification:In vitro screening with an LPS-induced neuroinflammatory cell model and in vivo validation in 5xFAD mice[J].中医药科学(英文),2026,4(3):255-269,15.基金项目
This work was supported by the Scientific and Technological Innovation Project of the China Academy of Chinese Medical Sciences(Grant Nos.CI2024E003 KC-05,CI2023E001TS09,CI2023C020YL,CI2021A04510),the Beijing Natural Science Foundation(Grant No.7254509),the Fundamental Research Funds for the Central Public Welfare Research Institutes of China(Grant Nos.ZZ15-YQ-032,ZZ17-YQ-015),and the Innovative Team of Traditional Chinese Medicine Toxicology(Grant No.CI2021B016). (Grant Nos.CI2024E003 KC-05,CI2023E001TS09,CI2023C020YL,CI2021A04510)